EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer patients who Can't tolerate standard hormone therapy
Disease control Not yet recruitingThis study is for 300 women with early-stage, hormone-sensitive breast cancer who had to stop their usual hormone pills due to side effects. It tests a different drug, giredestrant, to see if women stick with it and how it affects their symptoms and quality of life. The goal is t…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 17, 2026 03:15 UTC
-
Could a simple genetic test spare young breast cancer patients from chemo?
Disease control Not yet recruitingThis study aims to see if a genetic test (Prosigna®) can help decide whether younger women with a common type of early breast cancer (HR+/HER2-) can safely skip chemotherapy and receive only hormone therapy. About 3,380 premenopausal women will be randomly assigned to either stan…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Which Post-Chemo treatment gives best results for HER2+ breast cancer?
Knowledge-focused Not yet recruitingThis study looks at 2,000 people with HER2-positive early breast cancer who still had cancer cells after initial treatment. Researchers compare two follow-up drug plans to see which one better prevents the cancer from coming back over three years. The goal is to find the most eff…
Matched conditions: EARLY BREAST CANCER
Sponsor: Hebei Medical University Fourth Hospital • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:12 UTC
-
Breast cancer study to track Real-World use of newer pills
Knowledge-focused Not yet recruitingThis study will follow 81 people with early-stage, hormone-positive breast cancer who are at high risk of the cancer coming back. Researchers want to see how often patients take their prescribed CDK4/6 inhibitor pills (abemaciclib or ribociclib) alongside standard hormone therapy…
Matched conditions: EARLY BREAST CANCER
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
Massive study tracks breast cancer return in 100,000 korean patients
Knowledge-focused Not yet recruitingThis study will look back at the medical records of 100,000 people in Korea who had early-stage hormone receptor-positive, HER2-negative breast cancer and received surgery. The goal is to understand how often the cancer comes back and what factors might increase that risk. No new…
Matched conditions: EARLY BREAST CANCER
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC